BMY:NYE-Bristol-Myers Squibb Company (USD)

EQUITY | Drug Manufacturers—General | New York Stock Exchange

Last Closing

USD 58.25

Change

+1.35 (+2.37)%

Market Cap

USD 93.95B

Volume

0.02B

Analyst Target

USD 70.73
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-04-08 )

Largest Industry Peers for Drug Manufacturers—General

ETFs Containing BMY

MEDX Horizon Kinetics Medical .. 5.62 % 0.00 %

-0.15 (0.34%)

USD 0.75B
XGES:LSE Xtrackers MSCI Genomic He.. 4.14 % 0.00 %

+0.22 (+0.34%)

USD 3.60M
XDGI:XETRA Xtrackers MSCI Global SDG.. 3.43 % 0.00 %

+0.26 (+0.34%)

USD 0.01B
DHS:SW WisdomTree US Equity Inco.. 2.87 % 0.00 %

+0.25 (+0.34%)

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.87 % 0.00 %

N/A

USD 0.04B
TDGB:LSE VanEck Morningstar Develo.. 2.82 % 0.00 %

+0.17 (+0.34%)

USD 0.55B
TDIV:LSE VanEck Morningstar Develo.. 2.81 % 0.00 %

+0.22 (+0.34%)

USD 0.58B
TDIV:SW VanEck Morningstar Develo.. 2.69 % 0.00 %

+0.01 (+0.34%)

USD 0.58B
HEAL:CA 2.66 % 0.00 %

N/A

N/A
PUD.B:CA 1.82 % 0.66 %

N/A

N/A
UVDV 1.72 % 0.00 %

N/A

N/A
UC82:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

+0.25 (+0.34%)

USD 0.07B
UC86:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

-0.01 (0.34%)

USD 0.29B
SPXB ProShares S&P 500® Bond .. 1.32 % 0.15 %

+0.02 (+0.34%)

USD 9.35M
FELV Fidelity Enhanced Large C.. 0.98 % 0.00 %

+0.10 (+0.34%)

USD 1.93B
PAPI Parametric Equity Premium.. 0.81 % 0.00 %

+0.05 (+0.34%)

USD 0.02B
UC98:LSE UBS(Lux)Fund Solutions .. 0.74 % 0.00 %

+2.50 (+0.34%)

USD 0.18B
BSUS:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

+2.80 (+0.34%)

USD 0.06B
UC97:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

+0.04 (+0.34%)

USD 0.18B
UET0:F UBS (Lux) Fund Solutions .. 0.65 % 0.00 %

+0.04 (+0.34%)

N/A
UET0:XETRA UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.03 (+0.34%)

USD 0.21B
CBSUST:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.04 (+0.34%)

USD 0.03B
CBSUS:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.04 (+0.34%)

USD 0.18B
CBSUSE:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

-0.02 (0.34%)

USD 0.25B
CBSUSH:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

USD 0.06B
QUIG:CA Mackenzie US Investment G.. 0.62 % 0.28 %

+0.16 (+0.34%)

CAD 0.48B
FVD:LSE First Trust Value Line® .. 0.62 % 0.00 %

+0.27 (+0.34%)

USD 0.01B
UC76:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

+0.05 (+0.34%)

USD 0.07B
UC85:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

+4.50 (+0.34%)

USD 0.06B
DEW WisdomTree Global High Di.. 0.00 % 0.58 %

+0.25 (+0.34%)

USD 0.11B
DHS WisdomTree U.S. High Divi.. 0.00 % 0.38 %

+0.73 (+0.34%)

USD 1.05B
FTLS First Trust Long/Short Eq.. 0.00 % 1.59 %

+0.26 (+0.34%)

USD 1.04B
GBF iShares Government/Credit.. 0.00 % 0.20 %

-0.28 (0.34%)

USD 1.34B
IHE iShares U.S. Pharmaceutic.. 0.00 % 0.42 %

+0.20 (+0.34%)

USD 0.64B
JHMH 0.00 % 0.46 %

N/A

N/A
QLTA iShares Aaa - A Rated Cor.. 0.00 % 0.15 %

-0.06 (0.34%)

USD 1.04B
NUBD Nuveen ESG U.S. Aggregate.. 0.00 % 0.20 %

N/A

USD 0.34B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

-0.01 (0.34%)

USD 0.02B
HONR 0.00 % 0.65 %

N/A

N/A
DSTL Distillate US Fundamental.. 0.00 % 0.00 %

+0.20 (+0.34%)

USD 1.70B
RUD-U:CA RBC Quant U.S. Dividend L.. 0.00 % 0.00 %

N/A

N/A
HUL-U:CA 0.00 % 0.00 %

N/A

N/A
RUD:CA RBC Quant US Dividend Lea.. 0.00 % 0.43 %

+0.14 (+0.34%)

CAD 0.49B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.04 (0.34%)

USD 1.25M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.04 (0.34%)

USD 1.25M
SICK 0.00 % 0.95 %

N/A

N/A
UXM.B:CA 0.00 % 0.67 %

N/A

N/A
HUL:CA 0.00 % 2.20 %

N/A

N/A
BVAL 0.00 % 0.65 %

N/A

N/A
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+23.80 (+0.34%)

USD 0.03B
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.43 (+0.34%)

USD 0.04B
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.36 (+0.34%)

USD 0.03B
LUMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

+175.00 (+0.34%)

USD 0.01B
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

+3.50 (+0.34%)

USD 0.07B
USMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

+2.60 (+0.34%)

USD 0.01B
XSD2:LSE db x-trackers ShortDAX x2.. 0.00 % 0.00 %

-0.42 (0.34%)

USD 0.13B
MVUS:PA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

USD 0.01B
SPMV:PA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

USD 0.05B
OSX2:F Ossiam Lux - Ossiam US Mi.. 0.00 % 0.00 %

+2.85 (+0.34%)

N/A
WTD9:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.41 (+0.34%)

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

+0.28 (+0.34%)

USD 0.62M
WTEU:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.35 (+0.34%)

USD 0.11B
OSX2:XETRA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

+2.80 (+0.34%)

USD 0.12B
VDIV:XETRA VanEck Morningstar Develo.. 0.00 % 0.00 %

+0.22 (+0.34%)

USD 0.55B
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
WTD9:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

+0.40 (+0.34%)

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

+0.29 (+0.34%)

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.34 (+0.34%)

USD 0.11B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
KVLE KFA Value Line Dynamic Co.. 0.00 % 0.00 %

+0.14 (+0.34%)

USD 0.03B
TWIO Spinnaker ETF Series - Tr.. 0.00 % 0.00 %

-0.10 (0.34%)

USD 0.03B
HART IQ Healthy Hearts ETF 0.00 % 0.00 %

+0.04 (+0.34%)

USD 9.64M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers—General) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.25% 70% C- 77% C+
Dividend Return 1.40% 78% C+ 71% C-
Total Return -7.85% 60% D- 79% B-
Trailing 12 Months  
Capital Gain 26.69% 100% F 96% N/A
Dividend Return 3.74% 80% B- 74% C
Total Return 30.43% 100% F 96% N/A
Trailing 5 Years  
Capital Gain -8.21% 40% F 60% D-
Dividend Return 12.54% 30% F 50% F
Total Return 4.33% 40% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain -3.61% 18% F 18% F
Dividend Return -0.95% 18% F 18% F
Total Return 2.67% 36% F 56% F
Risk Return Profile  
Volatility (Standard Deviation) 16.64% 45% F 52% F
Risk Adjusted Return -5.70% 18% F 17% F
Market Capitalization 93.95B 50% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers—General) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 28.79 20% 18%
Price/Book Ratio 2.54 88% 26%
Price / Cash Flow Ratio 15.96 30% 18%
Price/Free Cash Flow Ratio 22.11 13% 10%
Management Effectiveness  
Return on Equity 10.51% 38% 60%
Return on Invested Capital 7.35% 20% 60%
Return on Assets 5.35% 33% 78%
Debt to Equity Ratio 84.09% 50% 42%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.